The control of sporulation and antibiotic production through c-di-GMP signaling
Project Number1R35GM156858-01
Contact PI/Project LeaderGALLAGHER, KELLEY ANN
Awardee OrganizationCORNELL UNIVERSITY
Description
Abstract Text
PROJECT SUMMARY
In all domains of life, cells must employ tightly controlled mechanisms to regulate global processes in response
to environmental inputs. In bacteria, signaling through the nucleotide second messenger 3’,5’-cyclic diguanylic
acid (c-di-GMP) is one of the most conserved mechanisms cells use to trigger lifestyle changes in response to
specific environmental cues. Although the enzymes that synthesize and degrade c-di-GMP can be found in all
bacterial phyla, studies of this second messenger have focused on model species belonging to the Phylum
Pseudomonadota. A key knowledge gap is understanding how this fundamental mechanism governs regulation
of gene expression in diverse bacterial phyla. This project will address this by characterizing the molecular
mechanisms and evolution of c-di-GMP signaling in the antibiotic-producing bacterial genus Streptomyces, which
belongs to Phylum Actinobacteria (synonym Actinomycetota). In Streptomyces, c-di-GMP is the central integrator
controlling a highly unusual life cycle that involves progression from vegetative growth to production of
reproductive aerial hyphae that differentiate into chains of spores. To investigate the molecular basis and
functional diversification of c-di-GMP signaling, this project will focus on three areas: (1) the mechanisms through
which c-di-GMP regulates progression through the developmental life cycle in the model species Streptomyces
venezuelae; (2) the evolution and distribution of conserved components of c-di-GMP signaling networks; and (3)
the impact of c-di-GMP on antibiotic biosynthesis, which is tightly controlled along with the developmental life
cycle, in diverse antibiotic-producing actinobacterial species. These studies will contribute to a fundamental
understanding of how bacterial control gene expression and will leverage this knowledge to manipulate antibiotic
production.
Public Health Relevance Statement
PROJECT NARRATIVE
The bacterial genus Streptomyces are our most important source of clinical antibiotics, which they produce
concomitant with a tightly regulated developmental life cycle that culminates in sporulation. This project will
characterize the key molecular mechanisms that underlie control of development in these bacteria and will
examine how these mechanisms have evolved. These studies will increase our fundamental understanding of
how bacteria regulate gene expression and antibiotic production.
No Sub Projects information available for 1R35GM156858-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R35GM156858-01
Patents
No Patents information available for 1R35GM156858-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R35GM156858-01
Clinical Studies
No Clinical Studies information available for 1R35GM156858-01
News and More
Related News Releases
No news release information available for 1R35GM156858-01
History
No Historical information available for 1R35GM156858-01
Similar Projects
No Similar Projects information available for 1R35GM156858-01